Company Encyclopedia
View More
name
Yifeng Pharmacy
603939.SH
Yifeng Pharmacy Chain Co., Ltd. engages in the retail business of pharmaceutical products in China. The company operates through Retail business and Wholesale business segments. It offers Western and Chinese patent medicine, traditional Chinese medicine herbal pieces, medical devices and equipment, health supplements and products, personal care products, drugs, and convenience products related to health.
90.72 B
603939.SHMarket value -Rank by Market Cap -/-

Financial Score

06/12/2025 Update
B
Drug RetailIndustry
Industry Ranking1/9
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE15.33%A
    • Profit Margin6.81%B
    • Gross Margin41.11%B
  • Growth ScoreC
    • Revenue YoY0.88%C
    • Net Profit YoY7.83%C
    • Total Assets YoY-4.19%D
    • Net Assets YoY9.02%B
  • Cash ScoreB
    • Cash Flow Margin1468.93%B
    • OCF YoY0.88%C
  • Operating ScoreA
    • Turnover0.91A
  • Debt ScoreC
    • Gearing Ratio54.42%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Yifeng Pharmacy Chain Vice Presidents Reduce Stakes

    Yifeng Pharmacy Chain Vice Presidents Reduce Stakes

    marketscreener·
    SH
    603939
    -0.09%
    marketscreener·
    SH
    603939
    -0.09%

    Hanshow Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025

    Hanshow Technology Co., Ltd. reported its earnings for the nine months ending September 30, 2025. The company experienced a decline in sales, reporting CNY 2,809.06 million, down from CNY 3,157.5 million the previous year. Net income also fell to CNY 314.39 million from CNY 528.47 million year-over-year. Basic and diluted earnings per share from continuing operations decreased to CNY 0.7624, compared to CNY 1.3901 a year ago.

    marketscreener·
    SZ
    301275
    +2.12%
    marketscreener·
    SZ
    301275
    +2.12%

    Yifeng Pharmacy released its performance for the first three quarters, with a net profit attributable to the parent company of 1.225 billion yuan, a year-on-year increase of 10.27%

    According to the Zhitong Finance APP, Yifeng Pharmacy disclosed its third-quarter report for 2025. The company achieved a revenue of 17.286 billion yuan in the first three quarters, a year-on-year increase of 0.39%; the net profit attributable to the parent company was 1.225 billion yuan, a year-on-year increase of 10.27%; the net profit excluding non-recurring gains and losses was 1.188 billion yuan, a year-on-year increase of 8.80%; the basic earnings per share were 1.01 yuan

    Zhitong·
    SH
    603939
    -0.09%
    Zhitong·
    SH
    603939
    -0.09%

    Yifeng Pharmacy Chain Q3 Net Profit Up 10.1% Y/Y

    Yifeng Pharmacy Chain Co Ltd :Q3 NET PROFIT UP 10.1% Y/Y

    Reuters·
    SH
    603939
    -0.09%
    Reuters·
    SH
    603939
    -0.09%

    Zhitong A-share lock-up release overview | October 27

    On October 27th, a total of 10 listed companies had their restricted shares unlocked, with a total market value of approximately 18.54 billion yuan. The specific situation of the restricted shares unlocked today is as follows: Stock Abbreviation Stock Code Restricted Share Type Unlocked Shares Xiamen Bank 601187 Extended Restricted Lock-up Period Circulation 1.348 billion GZYK 002524 Equity Incentive Restricted Circulation 2.2245 million SPAS 603168 Equity Incentive Restricted Circulation 30,000 Yifeng Pharmacy 603939 Equity Incentive Restricted Circulation 195,000 Jihong Co., Ltd. 002803 Equity Incentive Restricted Circulation 1.98 million Mingyang Circuit 300739 Equity Incentive Restricted Circulation 1.2387 million Arrow Home 001322 Pre-issue Shares Restricted Circulation 800 million Ruichen Environmental Protection 301273 Pre-issue Shares Restricted Circulation 37.0125 million Jinchengzi 688291 6.9 million Wei Ce Technology 688372 270.328 million

    Zhitong·
    SH
    601187
    -0.96%
    SZ
    002524
    +0.22%
    SH
    603939
    -0.09%
    Zhitong·
    SH
    601187
    -0.96%
    SZ
    002524
    +0.22%
    SH
    603939
    -0.09%
    © 2025 Longbridge｜Disclaimer